| NCT ID | NCT04192422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust |
| Condition | GDM |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2020-09-01 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We wish to study the effect of a mothers sugar (glucose) control during pregnancy on her baby's sugar control after birth.
Eligibility Criteria
Inclusion Criteria: * mothers and their babies who have been enrolled in DiGest Trial and who have provided informed consent Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04192422 clinical trial?
This trial is open to participants of all sexes, studying GDM. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04192422 currently recruiting?
Yes, NCT04192422 is actively recruiting participants. Contact the research team at kb274@cam.ac.uk for enrollment information.
Where is the NCT04192422 trial being conducted?
This trial is being conducted at Cambridge, United Kingdom.
Who is sponsoring the NCT04192422 clinical trial?
NCT04192422 is sponsored by Cambridge University Hospitals NHS Foundation Trust. The trial plans to enroll 60 participants.